图片 I

A Augusti XXVI ad August XXX, MMXXIV, jymmed scriptor peptide productio facilitas, Hubei Jx bio-pharmaceutical Co., Ltd., feliciter Transierunt an on-site inspectionem conducted per US cibum et medicamento administratione (FDA). Et inspectionem operuit key areas ut qualis ratio, productio ratio, apparatu et facility ratio, officinarum controls et materiae procuratio ratio.

图片 II

Hoc notas primum FDA inspectionem feliciter completur per Hubei Jx peptide productio facilitas. Secundum ad inspectionem fama, quod facilitas est qualis et productionem systems plene occursum FDA signa.

图片 III

Jymed se extendit sincere gratiam ad opportunum socium, Rochem, pro continua firmamentum in praeteritum et praesens FDA inspectionibus.

图片 IV

Hoc factum significat quod Hubei Jy scriptor peptide productio facilitas adhaeret FDA requisita ad qualis et productionem systems, determinativum est ingressum in US foro.

De jymmed

图片 V

Founded in MMIX, Shenzhen jymmed Technology Co., Ltd. est a biotechnology turba specialiter in independens investigationis, progressionem, productio, et Sales Peptide products, latere consuetudine peptide R & D et vestibulum officia. In turma offert super XX peptide apis, cum quinque products, inter semaglutide et Tirzepatide, habens feliciter complevit US FDA DMF limatura.

Et Hubei JX facilius features X productio lineas ad peptide apis (including gubernator-scale lineae), quod propinquos meos CGMP signa US, EU, Sinis. Et facilitas operatur comprehensive pharmaceutical qualis administratione ratio et EHS (environmental, salutem et salus) procuratio ratio. Hoc est Transierunt NMPA publica GMP inspectiones et EHS audits conducted a ducens global clients.

Core Services

1. procedat et internationalis peptide API adnotatione
2.veterinary et COLOR peptides
3.Custom peptide synthesis, cro, CMO et OEM Services
4.pdc (peptide conjugatibus), inter peptide-radionuclide, peptide-parva molecule, peptide, dapibus, et peptide-rna conjugat

图片 VI
VII 图片

Contactus notitia

图片 VIII
IX 图片

Oratio: 8th & 9th contignationibus, aedificationem I, Shenzhen biomedical innovation Industrial Park, Jin Hui Road XIV, Kengzi Street, Pingshan District, Shenzhen, Sina

Internationalis API Inquiries:
+ 86-755-26612112 | 86-15013529272

Nam domesticis medicamine peptide rudis materiae:
+ 86-755-26612112 | 86-15013529272

Nam domesticis API adnotatione et CDmo Services:
86-15818682250

Situs:www.jymedtech.com


Post tempus: Dec 11-2024